06826 HAOHAI BIOTEC
Closed Add to PorfolioKey Financial Ratio (Fiscal Year: 12/2024) | |||
Current | 4.22X | Oper Margin | 18.0% |
---|---|---|---|
LT Debt/Equity | 2.6% | Net Margin | 15.7% |
Total Debt/Equity | 8.0% | Return on Equity | 7.5% |
Price/Book | 1.11X | Return on Assets | 5.9% |
(HKD 28.550) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
Net Profit (MHKD) | 447.15 | 458.65 | 202.34 | 430.82 | 273.05 |
---|---|---|---|---|---|
Net Profit Growth (%) | -2.5 | +126.7 | -53.0 | +57.8 | -34.1 |
Earnings Per Share (HKD) | 1.918 | 1.933 | 0.833 | 1.747 | 1.101 |
Earnings Per Share Growth (%) | -0.8 | +132.1 | -52.3 | +58.8 | -39.4 |
Dividend Per Share (HKD) | 1.094 | 0.785 | 0.315 | 0.586 | 0.433 |
P/E* (X) | 14.88 | 14.77 | 34.29 | 16.34 | 25.94 |
Yield (%) | 3.83 | 2.75 | 1.10 | 2.05 | 1.52 |
Dividend Share (%) | 57.02 | 40.59 | 37.83 | 33.52 | 39.34 |
Book NAV (HKD) | 25.703 | 25.941 | 25.363 | 28.390 | 26.267 |
Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
(RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
Cover Period (mths) | 12 | 12 | NA | 12 |
---|---|---|---|---|
Turnover | 2,680 | 2,635 | +1.7 | 2,103 |
Operating Result | 465.159 | 507.177 | -8.3 | 232.036 |
Associates | 0.986 | 0.456 | +116.2 | 3.505 |
Profit Before Taxation | 466.145 | 508.26 | -8.3 | 235.726 |
Taxation | 89.902 | 95.991 | -6.3 | 45.395 |
Profit /( Loss) After Taxation | 376.243 | 412.269 | -8.7 | 190.331 |
Minority Interests | -44.204 | -3.852 | +1,047.6 | 9.861 |
Net Profit | 420.447 | 416.121 | +1.0 | 180.47 |
Earnings Per Share () | 1.9182 | 1.9327 | -0.8 | 0.8327 |
Dividend Per Share () | 1.0937 | 0.7845 | +39.4 | 0.3150 |
Announcement Date | 2025-03-21 | 2024-03-08 | NA | 2023-03-24 |
* Annualised
Last Update Time: 2025-07-22 21:40:25